SCHEMBL24817282

SCHEMBL24817282

CCOC(=O)OC1CCCCO1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.40
HPGD P15428 3/20 0.38
NPC1 O15118 1/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
RAB9A P51151 1/20 0.38
SOAT1 P35610 1/20 0.38
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 2/20 0.36
POLB P06746 1/20 0.35
TSHR P16473 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
THRB P10828 1/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17360020 0.95 HPGD (0.42) ALDH1A1HPGDNPC1TP53CYP1A2
SCHEMBL17360025 0.81 ALDH1A1 (0.41) ALDH1A1HPGDNPC1TP53CYP1A2
SCHEMBL28647211 0.81 MEN1 (0.38) ALDH1A1HPGDNPC1RAB9AMEN1
SCHEMBL7714291 0.80 SLC6A3 (0.41) ALDH1A1HPGDNPC1RAB9AMEN1
SCHEMBL18117298 0.80 HPGD (0.34) ALDH1A1HPGDNPC1TP53CYP1A2
SCHEMBL12046271 0.80 HPGD (0.34) ALDH1A1HPGDNPC1TP53CYP1A2
SCHEMBL17360032 0.79 RAB9A (0.43) ALDH1A1HPGDNPC1RAB9AMEN1
SCHEMBL20357987 0.79 CHRM2 (0.38) ALDH1A1MEN1KMT2APOLBLMNA
SCHEMBL3812571 0.79 CHRM2 (0.38) ALDH1A1MEN1KMT2APOLBLMNA
SCHEMBL2373828 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220411448-A1 CHROMENE-4-ONE DERIVATIVES AS BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) MIMETICS Floratek Pharma SA (CH) 2022-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411448-A1 CHROMENE-4-ONE DERIVATIVES AS BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) MIMETICS BDNF, NTRK2, NGF ALDH1A1 1628/4885HPGD 506/4885NPC1 1235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.